Low triiodothyronine (T3) or reverse triiodothyronine (rT 3) syndrome modifies gene expression in rats with congestive heart failure

Endocrine Research

Volumn 31, Issue 4, 2005, Pages 397-405

  Bauab, R C M ^a   Perone, D ^a   Castro, A V B ^a   Cicogna, A C ^a   Nogueira, C R ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Expression gene; Heart failure; Low T3

Indexed keywords

LIOTHYRONINE; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; THYROID HORMONE; THYROID HORMONE RECEPTOR ALPHA; 3,3',5' TRIIODOTHYRONINE; MESSENGER RNA; MYOSIN HEAVY CHAIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA STENOSIS; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEIODINATION; EUTHYROID SICK SYNDROME; GENE EXPRESSION; KIDNEY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HEART VENTRICLE; METABOLISM; NONPARAMETRIC TEST; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; EUTHYROID SICK SYNDROMES; GENE EXPRESSION REGULATION; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; MALE; MYOSIN HEAVY CHAINS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; THYROID HORMONE RECEPTORS ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRIIODOTHYRONINE; TRIIODOTHYRONINE, REVERSE;

EID: 32144450239     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.1080/07435800500467942     Document Type: Article

References (25)

1. Dilman WH. Cellular action of thyroid hormone on the heart. Thyroid 2002; 12:447-452.
2. Hamilton MA. Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure. Ann Thorac Surg 1993; 56:S - 48-53.
3. D' Amati G, Di Gioia CRT, Mentuccia D, Pistilli D, Proietti-Pannunzi L, Miraldi F, Gallo P, Celi FS. Increased expression of thyroid hormone receptor isoforms in end-stage human congestive heart failure. J Clin Endocrinol Metab 2001; 86:2080-2084.
4. Kinugawa K, Minobe WA, Wood WM, Ridgway EC, Baxter JD, Ribeiro RC, Tawadrous MF, Lowes BA, Long CS, Bristow MR. Signaling pathways responsible for fetal gene expression in the failing human heart: evidence for altered thyroid hormone receptor gene expression. Circulation 2001; 103:1089-1094.
5. Sylvén C, Jansson E, Sotonyi P, Waagstein F, Barkhem T, Brönnegard M. Cardiac nuclear hormone receptor mRNA in heart failure in man. Life Sci 1996; 59:1917-1922.
6. Shahrara S, Tidholm A, Drvota V, Häggstöm J, Sylvén C. Upregulation of thyroid hormone receptor β1 and β2 messenger RNA in the myocardium of dogs with dilated cardiomyopathy or chronic valvular disease. Am J Vet Res 1999; 60(7):848-852.
7. Chopra IJ. A study of extrathyroidal conversion of thyroxine (T4) to 3,3′,5-triiodothyronine (T3) in vitro. Endocrinology 1977; 101:453-463.
8. Bristow MR, Minobe WA, Raynobs MV, Port JD, Rasmussen R, Ray PE, Feldman AM. Reduced beta 1 receptor messenger RNA abundance in the failing human heart. J Clin Invest 1993; 92:2737-2745.
9. Chomcznski P, Sacchi N. Single step method of RNA isolation by acid guanidium-thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
10. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: a laboratory manual , 2nd Ed;. Cold Spring Harbor Laboratory: New York, 1989.
11. Nakao K, Minobe W, Roden R, Bristow MR, Linwand LA. Myosin heavy chain gene expression in human heart failure. J Clin Invest 1997; 100:2362-2370.
12. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Qualife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert EM. Changes in gene expression in the intact human heart: downregulation of alpha-myosin heavy chain in hypertrophied, filing ventricular myocardium. J Clin Invest 1977; 100:2314-2314.
13. Conrad CH, Brooks WW, Robinson KG, Bing OHL. Impaired myocardial function in spontaneously hypertensive rats with heart failure. Am J Physiol 1991; 260:H136-H145.
14. Boluyt MO, O'Neill L, Meredith Al, Bing OHL, Brooks WW, Conrad CH, Crow MT, Lakatta EG. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure: marked up regulation of genes encoding extracellular matrix components. Circ Res 1994; 75:23-32.
15. Boluyt OHL, Bing OHL, Lakatta EG. The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure. Eur Heart J 1995; 16:19-30.
16. Cicogna AC, Brooks WW, Hayes JA, Robinson KG, Sen S, Conrad CH, Bing OH. Effect of chronic colchicines administration on the myocardium of the aging spontaneously hypertensive rat. Mol Cell Biochem 1997; 166:45-54.
17. Hamilton MA, Stevenson LW, Luu M, Walden JA. Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 1990; 16:91-5.
18. Klemperer JD, Ojamaa K, Klein I. Thyroid hormone therapy in cardiovascular disease. Prog Cardiovasc Dis 1996; 38:329-36.
19. Morkin E, Pennock GD, Raya TE, Bahl JJ, Goldman S. Studies on the use of thyroid hormone and a thyroid hormone analogue in the treatment of congestive heart failure. Ann Thorac Surg 1993; 5:S54-S60.
20. Gomberg-Maitland M, Frishman WH. Thyroid hormone and cardiovascular disease. Am Heart J 1998; 135:187-96.
21. Wassen FWJS, Schiel AE, Kuiper GGJM, Kaptein E, Bakker O, Visser TJ, Simonides WS. Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. Endocrinology 2002; 143:2812-2815.
22. Hamilton MA, Stevenson LW, Fonarow GC, Steimle A, Goldhaber JI, Child JS, Chopra IJ, Moriguchi JD, Hage A. Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol 1998; 81:443-447.
23. Malik FS, Mehra MR, Uber PA, Park MH, Scott RL, Van Meter CH. Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock. J Cardiac Failure 1999; 5:31-37.
24. Novitsky D, Fontanet H, Snyder M, Coblio N, Smith D, Parsonnet V. Impact of triiodothyronine on survival of high-risk patients undergoing open heart surgery. Cardiology 1996; 87:509-515.
25. Cimochowski GE, Harostock MD, Foldes PJ. Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventricular dysfunction by maximization of metabolic and mechanical support. J Thorac Cardiovasc Surg 1997; 113:655-666.